BioWorld MedTech

May 1, 2018

View Archived Issues

Medtronic's Infuse gains FDA sign off for use with additional spine implants

The FDA has approved Medtronic plc's Infuse bone graft for new spine surgery indications, marking the second expanded indication for the product in two years. Read More

Inari Medical shares positive results from FLARE study of Flowtriever PE device

Read More

U.S. trade report takes aim at unfair practices in drug, device sectors

Read More

3D medical printing companies looking to tamp down the hype

Read More

Australia's Telix forges global partnerships to harness power of radiopharmaceuticals

Read More

Appointments and advancements

Read More

Daily M&A

Read More

Financings

Read More

Product briefs

Read More

Other news to note

Read More

BioWorld MedTech's Cardiology Extra

Read More